鸟苷酸结合蛋白5调控类风湿关节炎滑膜成纤维细胞的炎症与组织破坏
该研究探讨了GBP-5在类风湿关节炎(RA)发病中的作用。在RA滑膜组织和佐剂诱导性关节炎(AIA)大鼠关节中GBP-5选择性上调,且被IL-1β、TNF和/或IFNγ诱导。敲低GBP-5可放大IL-1β诱导的IL-6、IL-8、CXCL5和MMP-1产生,并增加IFNγ诱导的RASFs增殖和迁移;体内敲低GBP-5加重AIA大鼠疾病发作、严重程度、滑膜炎和骨破坏。
要点
- GBP-5在RA滑膜组织和AIA大鼠关节中选择性上调,并被促炎细胞因子诱导。
- 敲低GBP-5放大IL-1β诱导的IL-6、IL-8、CXCL5及MMP-1产生。
- 关节腔内siRNA敲低GBP-5加重AIA大鼠滑膜炎和骨破坏。
核心结论
- RASFs响应细胞因子刺激表达GBP-5,GBP-5有潜力恢复细胞稳态并减弱RA炎症和组织破坏。
研究设计与样本
- 研究在RA滑膜组织与未受RA影响的滑膜组织中用qRT-PCR评估GBP1-GBP7转录本表达。
- 在人RASFs中采用瞬时siRNA敲低和慢病毒过表达研究GBP-5对促炎细胞因子信号通路的调控作用。
- 采用无偏全转录组RNA测序分析评估GBP-5对RASFs分子功能的影响,并用佐剂诱导性关节炎(AIA)大鼠模型体内验证。
主要发现
- GBP-5在RA滑膜组织中选择性上调(P < 0.05;n = 4),在AIA大鼠关节中上调(P < 0.05;n = 6)。
- 人RASFs中GBP-5被IL-1β、TNF和/或IFNγ显著诱导(P < 0.05;n = 3)。
- RNA测序生物信息学分析确定细胞因子-细胞因子受体信号为GBP-5改变的主要功能,IL-6信号为主要靶点。
- 敲低GBP-5使IL-1β诱导的IL-6、IL-8、ENA-78/CXCL5产生分别放大44%、54%、45%,MMP-1产生放大数倍,外源给予GBP-5可逆转。
- 缺乏GBP-5增加IFNγ诱导的人RASFs增殖和迁移;关节腔内siRNA敲低GBP-5加重AIA大鼠疾病发作、严重程度、滑膜炎和骨破坏。
临床怎么用
- GBP-5可能作为RA中限制滑膜炎症和关节破坏的潜在靶点,但尚需临床研究验证。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Rheumatoid arthritis synovial fibroblasts (RASFs) are crucial mediators of synovial inflammation and joint destruction. However, their intrinsic immunoregulatory mechanisms under chronic inflammation remain unclear. Thus, the present study was undertaken to understand the role of a newly identified GTPase, guanylate binding protein 5 (GBP-5), in RA pathogenesis. METHODS: The expression of GBP1-GBP7 transcripts was evaluated using quantitative reverse transcription-polymerase chain reaction in RA synovial tissue or synovial tissue unaffected by RA. Our investigation on transient small interfering RNA (siRNA) knockdown and lentiviral overexpression in human RASFs examined the regulatory role of GBP-5 on proinflammatory cytokine signaling pathways. Unbiased whole transcriptome RNA sequencing analysis was used to assess the impact of GBP-5 on RASF molecular functions. These findings were confirmed using a rat model of adjuvant-induced arthritis (AIA) in vivo. RESULTS: Among different GBPs evaluated, GBP-5 was selectively up-regulated in RA synovial tissue (P < 0.05; n = 4) and in the joints of rats with AIA (P < 0.05; n = 6) and was significantly induced in human RASFs by interleukin-1β (IL-1β), tumor necrosis factor (TNF), and/or interferon-γ (IFNγ) (P < 0.05; n = 3). Bioinformatics analysis of RNA sequencing data identified cytokine-cytokine receptor signaling as a major function altered by GBP-5, with IL-6 signaling as a primary target. Knockdown of GBP-5 amplified IL-1β-induced IL-6, IL-8, and epithelial neutrophil-activating peptide 78/CXCL5 production by 44%, 54%, 45%, respectively, and matrix metalloproteinase 1 (MMP-1) production by several-fold-effects that reversed with exogenously delivered GBP-5. Lack of GBP-5 increased IFNγ-induced proliferation and migration of human RASFs. GBP-5 knockdown in vivo using intraarticular siRNA exacerbated disease onset, severity, synovitis, and bone destruction in rat AIA. CONCLUSION: Expressed by RASFs in response to cytokine stimulation, GBP-5 has potential to restore cellular homeostasis and blunt inflammation and tissue destruction in RA.
引用
- Haque M, Singh AK, Ouseph MM, et al. Regulation of Synovial Inflammation and Tissue Destruction by Guanylate Binding Protein 5 in Synovial Fibroblasts From Patients With Rheumatoid Arthritis and Rats With Adjuvant-Induced Arthritis. Arthritis Rheumatol. 2021. PMID: 33615742. doi:10.1002/art.41611
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。